ContextLogic Inc - Ordinary Shares - Class A
LOGC
Market Cap$217.99M
Close$
$1.82
77.7% downside
Current Fair Value
77.7% downsideOvervalued by 77.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $217.99 Million |
|---|---|
| Enterprise Value | $153.99 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.92 |
| Beta | 2.03 |
| Outstanding Shares | 26,306,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -10.75 |
|---|---|
| PEG | 11.53 |
| Price to Sales | - |
| Price to Book Ratio | 1.02 |
| Enterprise Value to Revenue | 22 |
| Enterprise Value to EBIT | -4.81 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About LogicBio Therapeutics Inc
39 employees
CEO: Frederic Chereau LogicBio Therapeutics is a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare and serious diseases from infancy through adulthood. The company's proprietary GeneRide™ platform is a...